ARTICLE | Clinical News
2-methoxyestradiol: Phase II data
October 29, 2007 7:00 AM UTC
In an open-label Phase II trial in 18 platinum refractory epithelial ovarian cancer patients, 1,000 mg of oral Panzem NCD given 4 times daily produced 1 confirmed partial response and 5 cases of stabl...